Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section wording updated to state PubMed-sourced publications are automatically filled, with a new revision note (v3.3.2). The previous description about PubMed data and automatic listing by NCT number has been revised (v3.2.0).SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the funding/operating-status notice banner from the page, and the NIH Clinical Center operating status message is no longer displayed.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected on the page; the NCT02267603 study details for Pembrolizumab in Merkel cell carcinoma remain as published, including the overview and eligibility criteria.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate to version v3.2.0 and removal of a specific resource (Cutaneous neuroendocrine carcinoma); addition of an important government-operating status notice and links.SummaryDifference2%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.0%

- Check92 days agoChange DetectedVersion bumped to v3.0.2 and the Back to Top element removed. No significant core content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.